Muscle Atrophy clinical trials at University of California Health

1 research study open to eligible people

Safety and Tolerability of IMMUNA(IMM01-STEM) in Patients With Muscle Atrophy Related to Knee Osteoarthritis.
open to eligible people ages 50-75
An open-label dose escalation study to assess the safety and tolerability of IMMUNA(IMM01-STEM) in participants with muscle atrophy related to knee osteoarthritis
at UC Irvine

Last updated: June 21, 2023